Use of antagonist anti-CD40 antibodies for treatment of chronic lymphocytic leukemia

Details for Australian Patent Application No. 2004287480 (hide)

International Classifications

Event Publications

22 June 2006 Amendment Made

The nature of the amendment is: Amend the name of the inventor from Aukerman, Lea to Aukerman, Susan Lea

22 June 2006 PCT application entered the National Phase

PCT publication WO2005/044304 Priority application(s): WO2005/044304

20 November 2008 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics, Inc.

25 August 2011 Assignment before Grant

Novartis Vaccines and Diagnostics, Inc. The application has been assigned to Novartis Vaccines and Diagnostics, Inc.; Xoma Technology Ltd.

15 September 2011 Application Accepted

Published as AU-B-2004287480

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.